Alerts will be sent to your verified email
Verify EmailFERMENTA
Fermenta Biotech
|
Abbott India
|
Mankind Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
3.87 % | 0.02 % | 2.15 % |
Financials
|
|||
5 yr Average ROE
|
13.3 % | 26.29 % | 23.48 % |
5yr average Equity Multiplier
|
2.01 | 1.46 | 1.4 |
5yr Average Asset Turnover Ratio
|
0.57 | 1.18 | 1.02 |
5yr Avg Net Profit Margin
|
10.11 % | 15.35 % | 16.52 % |
Price to Book
|
1.88 | 17.58 | 11.38 |
P/E
|
0.0 | 47.72 | 55.54 |
5yr Avg Cash Conversion Cycle
|
87.0 Days | -44.73 Days | -45.92 Days |
Inventory Days
|
127.28 Days | 51.2 Days | 60.23 Days |
Days Receivable
|
67.14 Days | 20.12 Days | 19.33 Days |
Days Payable
|
138.62 Days | 107.05 Days | 132.42 Days |
5yr Average Interest Coverage Ratio
|
3.0 | 119.35 | 47.23 |
5yr Avg ROCE
|
15.8 % | 34.73 % | 31.06 % |
5yr Avg Operating Profit Margin
|
23.21 % | 22.64 % | 25.32 % |
5 yr average Debt to Equity
|
0.7 | 0.0 | 0.07 |
5yr CAGR Net Profit
|
n/a | 16.09 % | 17.25 % |
5yr Average Return on Assets
|
6.54 % | 18.03 % | 16.73 % |
Shareholdings
|
|||
Promoter Holding
|
62.06 % | 74.99 % | 74.88 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
2.62 % | 0.0 | -1.62 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.24 % | 4.35 % | 6.74 % |
Fermenta Biotech
|
Abbott India
|
Mankind Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|